Concepedia

High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration

P. Benedetti Panici, Luca Pierelli, Giovanni Scambia, M.L. Foddai, MG Salerno, G Menichella, F Maneschi, U Caracussi, R. Serafini, Giuseppe Leone,

British Journal of Cancer · 1997 · 20 citations · 43 references

DOIFull text

Open access

Concepts

References

43

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

William Sheridan, R. M. Fox, C. Glenn Begley et al. · The Lancet · 1992 · 880 citations

, , +15

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern et al. · The Lancet · 1989 · 752 citations

, , +10

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

W. P. Peters, Maureen Ross, James J. Vredenburgh et al. · Journal of Clinical Oncology · 1993 · 502 citations

, , +10

Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.

Luen Bik To, Marion M. Roberts, David N. Haylock et al. · PubMed · 1992 · 414 citations

, , +10

Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor

Jack W. Singer, F R Appelbaum, K Lilleby et al. · Blood · 1993 · 375 citations · Full text

, , +11